Actionable pharmacogenetic variants in Hong Kong Chinese exome sequencing data and projected prescription impact in the Hong Kong population.
Plos Genetics
Yu, Mullin Ho Chung MHC; Chan, Marcus Chun Yin MCY; Chung, Claudia Ching Yan CCY; Li, Andrew Wang Tat AWT; Yip, Chara Yin Wa CYW; Mak, Christopher Chun Yu CCY; Chau, Jeffrey Fong Ting JFT; Lee, Mianne M; Fung, Jasmine Lee Fong JLF; Tsang, Mandy Ho Yin MHY; Chan, Joshua Chun Ki JCK; Wong, Wilfred Hing Sang WHS; Yang, Jing J; Chui, William Chun Ming WCM; Chung, Patrick Ho Yu PHY; Yang, Wanling W; Lee, So Lun SL; Chan, Godfrey Chi Fung GCF; Tam, Paul Kwong Hang PKH; Lau, Yu Lung YL; Tang, Clara Sze Man CSM; Yeung, Kit San KS; Chung, Brian Hon Yin BHY
Effect of sex and polymorphisms of CYP2B6 and UGT1A9 on the difference between the target-controlled infusion predicted and measured plasma propofol concentration.
Ja Clinical Reports
Fujita, Ai A; Hayamizu, Kengo K; Yoshihara, Tatsuya T; Zaitsu, Masayoshi M; Shiraishi, Fumie F; Arima, Hisatomi H; Matsuo, Kazumasa K; Shiokawa, Kanako K; Setoguchi, Hidekazu H; Sasaguri, Toshiyuki T
The impact of genetic polymorphisms on the pharmacokinetics of efavirenz in African children.
British Journal Of Clinical Pharmacology
Bienczak, Andrzej A; Cook, Adrian A; Wiesner, Lubbe L; Olagunju, Adeniyi A; Mulenga, Veronica V; Kityo, Cissy C; Kekitiinwa, Addy A; Owen, Andrew A; Walker, A Sarah AS; Gibb, Diana M DM; McIlleron, Helen H; Burger, David D; Denti, Paolo P
The Affymetrix DMET Plus platform reveals unique distribution of ADME-related variants in ethnic Arabs.
Disease Markers
Wakil, Salma M SM; Nguyen, Cao C; Muiya, Nzioka P NP; Andres, Editha E; Lykowska-Tarnowska, Agnieszka A; Baz, Batoul B; Tahir, Asma I AI; Meyer, Brian F BF; Morahan, Grant G; Dzimiri, Nduna N
Presence of the CYP2B6 516G> T polymorphism, increased plasma Efavirenz concentrations and early neuropsychiatric side effects in South African HIV-infected patients.
Aids Research And Therapy
Gounden, Verena V; van Niekerk, Chantal C; Snyman, Tracy T; George, Jaya A JA